Patient Compliance and Angiotensin Converting Enzyme Inhibitors in Hypertension

Publisher Website
Google Scholar
Abstract
Patient compliance is crucial to successful medical treatment. Many factors contribute to compliance, including age, sex. other sociodemographic factors, finances, intelligence, complexity of therapeutic regimen, and patient-physician rapport. Compliance is especially critical in medical conditions requiring prolonged therapy, such as hypertension. Historically, compliance among hypertensive patients has been alarmingly poor, with a 50% drop-off after I year and fewer than 20% still in therapy after 5 years. The use of enalapril, the long-acting angiotensin converting enzyme (ACE) inhibitor that allows for a once-daily regimen, has improved treatment success and compliance. This probably is due to the efficacy of the drug, coupled with a low incidence of side effects.

This publication has 0 references indexed in Scilit: